Annual Cash & Cash Equivalents
$18.32 M
-$1.44 M-7.27%
December 31, 2023
Summary
- As of February 8, 2025, CPIX annual cash & cash equivalents is $18.32 million, with the most recent change of -$1.44 million (-7.27%) on December 31, 2023.
- During the last 3 years, CPIX annual cash & cash equivalents has fallen by -$6.43 million (-25.98%).
- CPIX annual cash & cash equivalents is now -76.72% below its all-time high of $78.70 million, reached on December 31, 2009.
Performance
CPIX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$17.46 M
+$128.40 K+0.74%
September 30, 2024
Summary
- As of February 8, 2025, CPIX quarterly cash and cash equivalents is $17.46 million, with the most recent change of +$128.40 thousand (+0.74%) on September 30, 2024.
- Over the past year, CPIX quarterly cash and cash equivalents has dropped by -$856.80 thousand (-4.68%).
- CPIX quarterly cash and cash equivalents is now -78.04% below its all-time high of $79.54 million, reached on September 30, 2009.
Performance
CPIX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CPIX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -7.3% | -4.7% |
| 3 y3 years | -26.0% | -32.4% |
| 5 y5 years | -34.4% | -38.1% |
CPIX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -32.2% | at low | -35.4% | +6.6% |
| 5 y | 5-year | -35.1% | at low | -38.1% | +6.6% |
| alltime | all time | -76.7% | +230.9% | -78.0% | +179.2% |
Cumberland Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $17.46 M(+0.7%) |
| Jun 2024 | - | $17.34 M(-6.5%) |
| Mar 2024 | - | $18.55 M(+1.2%) |
| Dec 2023 | $18.32 M(-7.3%) | $18.32 M(-1.0%) |
| Sep 2023 | - | $18.51 M(+1.4%) |
| Jun 2023 | - | $18.25 M(+11.4%) |
| Mar 2023 | - | $16.39 M(-17.1%) |
| Dec 2022 | $19.76 M(-26.9%) | $19.76 M(+1.1%) |
| Sep 2022 | - | $19.54 M(+7.3%) |
| Jun 2022 | - | $18.22 M(+5.5%) |
| Mar 2022 | - | $17.27 M(-36.1%) |
| Dec 2021 | $27.04 M(+9.2%) | $27.04 M(+4.6%) |
| Sep 2021 | - | $25.84 M(+0.7%) |
| Jun 2021 | - | $25.67 M(+3.0%) |
| Mar 2021 | - | $24.92 M(+0.7%) |
| Dec 2020 | $24.75 M(-12.3%) | $24.75 M(-7.1%) |
| Sep 2020 | - | $26.65 M(-2.7%) |
| Jun 2020 | - | $27.37 M(+1.3%) |
| Mar 2020 | - | $27.03 M(-4.2%) |
| Dec 2019 | $28.21 M(+1.0%) | $28.21 M(+4.6%) |
| Sep 2019 | - | $26.98 M(+28.8%) |
| Jun 2019 | - | $20.95 M(-14.9%) |
| Mar 2019 | - | $24.61 M(-11.9%) |
| Dec 2018 | $27.94 M(-38.5%) | $27.94 M(-27.0%) |
| Sep 2018 | - | $38.26 M(+6.6%) |
| Jun 2018 | - | $35.91 M(+1.8%) |
| Mar 2018 | - | $35.26 M(-22.4%) |
| Dec 2017 | $45.41 M(+31.6%) | $45.41 M(+8.1%) |
| Sep 2017 | - | $42.02 M(+21.4%) |
| Jun 2017 | - | $34.62 M(-1.0%) |
| Mar 2017 | - | $34.97 M(+1.3%) |
| Dec 2016 | $34.51 M(-9.7%) | $34.51 M(-2.9%) |
| Sep 2016 | - | $35.55 M(-0.8%) |
| Jun 2016 | - | $35.84 M(-1.7%) |
| Mar 2016 | - | $36.44 M(-4.6%) |
| Dec 2015 | $38.20 M | $38.20 M(-0.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2015 | - | $38.32 M(-1.6%) |
| Jun 2015 | - | $38.94 M(-0.3%) |
| Mar 2015 | - | $39.04 M(-2.1%) |
| Dec 2014 | $39.87 M(-2.5%) | $39.87 M(+0.6%) |
| Sep 2014 | - | $39.64 M(+1.5%) |
| Jun 2014 | - | $39.05 M(+0.0%) |
| Mar 2014 | - | $39.05 M(-4.5%) |
| Dec 2013 | $40.87 M(-24.8%) | $40.87 M(-11.2%) |
| Sep 2013 | - | $46.01 M(-7.4%) |
| Jun 2013 | - | $49.66 M(-3.0%) |
| Mar 2013 | - | $51.21 M(-5.8%) |
| Dec 2012 | $54.35 M(-23.0%) | $54.35 M(+7.0%) |
| Sep 2012 | - | $50.80 M(-2.8%) |
| Jun 2012 | - | $52.27 M(-6.1%) |
| Mar 2012 | - | $55.64 M(-21.2%) |
| Dec 2011 | $70.60 M(+7.1%) | $70.60 M(-0.7%) |
| Sep 2011 | - | $71.07 M(+1.8%) |
| Jun 2011 | - | $69.83 M(+5.9%) |
| Mar 2011 | - | $65.96 M(+0.1%) |
| Dec 2010 | $65.89 M(-16.3%) | $65.89 M(+0.6%) |
| Sep 2010 | - | $65.52 M(-8.4%) |
| Jun 2010 | - | $71.50 M(-3.1%) |
| Mar 2010 | - | $73.75 M(-6.3%) |
| Dec 2009 | $78.70 M(+565.3%) | $78.70 M(-1.1%) |
| Sep 2009 | - | $79.54 M(+534.8%) |
| Jun 2009 | - | $12.53 M(+24.4%) |
| Mar 2009 | - | $10.07 M(-14.9%) |
| Dec 2008 | $11.83 M(+9.4%) | $11.83 M(+6.0%) |
| Sep 2008 | - | $11.16 M(+8.2%) |
| Jun 2008 | - | $10.32 M(-13.4%) |
| Mar 2008 | - | $11.91 M(+10.2%) |
| Dec 2007 | $10.81 M(+72.9%) | $10.81 M(+18.0%) |
| Sep 2007 | - | $9.17 M(-3.3%) |
| Jun 2007 | - | $9.48 M(+5.3%) |
| Mar 2007 | - | $9.00 M(+43.9%) |
| Dec 2006 | $6.26 M(+13.0%) | $6.26 M |
| Dec 2005 | $5.54 M | - |
FAQ
- What is Cumberland Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Cumberland Pharmaceuticals?
- What is Cumberland Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Cumberland Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Cumberland Pharmaceuticals?
- What is Cumberland Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Cumberland Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of CPIX is $18.32 M
What is the all time high annual cash & cash equivalents for Cumberland Pharmaceuticals?
Cumberland Pharmaceuticals all-time high annual cash & cash equivalents is $78.70 M
What is Cumberland Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, CPIX annual cash & cash equivalents has changed by -$1.44 M (-7.27%)
What is Cumberland Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CPIX is $17.46 M
What is the all time high quarterly cash and cash equivalents for Cumberland Pharmaceuticals?
Cumberland Pharmaceuticals all-time high quarterly cash and cash equivalents is $79.54 M
What is Cumberland Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, CPIX quarterly cash and cash equivalents has changed by -$856.80 K (-4.68%)